Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
07/2004
07/24/2004WO2003059904A1 Heteroaryl substituted pyrrole modulators of metabotropic glutamate receptor-5
07/22/2004WO2004061084A2 Modulation of protein functionalities
07/22/2004WO2004060883A1 Pyrimidine-4,6-dicarboxylic acid diamides for use as selective mmp 13 inhibitors
07/22/2004WO2004060874A1 Imino acid derivatives for use as inhibitors of matrix metalloproteinases
07/22/2004WO2004060367A1 Imidazole and triazole derivatives useful as selective cox-1 inhibitors
07/22/2004WO2004060308A2 Thiosemicarbazones as anti-virals and immunopotentiators
07/22/2004WO2004060306A2 Anti-inflammatory medicaments
07/22/2004WO2004060305A2 Anti-cancer medicaments
07/22/2004WO2004029045A3 Process for preparing quinazoline rho-kinase inhibitors and intermediates thereof
07/22/2004WO2003087086A3 Substituted indoles
07/22/2004WO2003044014A8 Indole-2-carboxamides as factor xa inhibitors
07/22/2004WO2002088090A3 Pyrazole derived kinase inhibitors
07/22/2004US20040143116 Sulfamoyl compounds and agricultural and horticultural fungicides
07/22/2004US20040143115 e.g., 1-[2-Benzoxazol-2-ylaminomethyl)-piperidin-1-yl]-1-(2-methyl-5phenyl-thiazol4-yl)-methanone; used to treat disorders where an antagonist of a human orexin receptor is required
07/22/2004US20040143018 Thrombosis; emphysema; antihistamines; cirrhosis; antiarthritic agents; anticancer agenst
07/22/2004US20040143003 Cyclopropylindole derivatives as selective serotonin reuptake inhibitors
07/22/2004US20040142997 Alzheimer's disease
07/22/2004US20040142987 3-aminoalkyl-2-aryl-indole derivatives and their use as gnrh antagonists
07/22/2004US20040142981 Sterilization, antiseptics for bacteria infections
07/22/2004US20040142975 Antiarthritic agents; canticancer agents; antitumor agents; cardiovascular diosrders; skin diosrders; vision defects; antiinflammatory agents
07/22/2004US20040142971 Benzothiophene compounds having antiinfective activity
07/22/2004US20040142963 Cardiovascular disorders
07/22/2004US20040142953 Inhibitors of histone deacetylase
07/22/2004US20040142949 Compounds, compositions, and methods
07/22/2004US20040142940 indole derivatives substituted by an amine at position 1, coupled to piperazine- or piperidine-type moieties anti-inflammatory agents
07/22/2004US20040142933 treatment of schizophrenia and other central nervous system (CNS) disorders
07/22/2004US20040142930 excellent phosphodiesterase V (PDE V) inhibitory activity, and being useful as a remedy for the prophylaxis or treatment of penile erectile dysfunction with few side effects
07/22/2004US20040142925 Piperazine derivatives their preparation and uses in therapy
07/22/2004US20040142923 inhibitors of urotensin II
07/22/2004DE10300398A1 Verwendung von substituierten 2-Phenylbenzimidazolen als Arzneimittel Use of substituted 2-Phenylbenzimidazolen as drugs
07/22/2004CA2513627A1 Anti-inflammatory medicaments
07/22/2004CA2512346A1 Imino acid derivatives for use as inhibitors of matrix metalloproteinases
07/22/2004CA2512183A1 Pyrimidine-4,6-dicarboxylic acid diamides for use as selective mmp 13 inhibitors
07/22/2004CA2511873A1 Modulation of protein functionalities
07/22/2004CA2511840A1 Anti-cancer medicaments
07/22/2004CA2511646A1 Thiosemicarbazones as anti-virals and immunopotentiators
07/21/2004EP1439174A1 4-imidazolin-2-one compounds
07/21/2004EP1438973A1 Remedies for stress diseases comprising mitochondrial benzodiazepine receptor antagonists
07/21/2004EP1438298A1 Piperazine derivatives with ccr1 receptor antagonist activity
07/21/2004EP1438296A2 1h-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1- antagonistic activity
07/21/2004EP1438292A1 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade
07/21/2004EP1438053A1 Pyrimidine derivatives, pharmaceutical agent containing said compounds, use and method for making same
07/21/2004EP1438052A1 INHIBITORS OF HUMAN PHOSPHATIDYL−INOSITOL 3−KINASE DELTA
07/21/2004EP1438027A1 Methods of treatment using a gastric retained losartan dosage
07/21/2004EP1100786B1 Antiviral pyrimidinedione derivatives and process for the preparation thereof
07/21/2004EP0937040B1 N-substituted 2-cyanopyrrolidines
07/21/2004CN1514833A Novel tyrosine kinase inhibitors
07/21/2004CN1514829A Novel herbicides
07/21/2004CN1514828A Pyrazole derivatives for treating HIV
07/21/2004CN1513865A Antitumour indolo pyrrolo carbazole derivatives
07/21/2004CN1513844A New Carboxglic acid derivative, its preparation and application
07/21/2004CN1158278C Sulfamoyl compounds and agricultural or horticultural bactericide
07/21/2004CN1158256C Pyrrolidine derivatives-CCR-3 receptor antagonists
07/20/2004US6765013 Thiazolidinedione derivatives for the treatment of diabetes and other diseases
07/20/2004US6765012 For modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation
07/20/2004US6765008 Pyrrolopyrimidines as CRF antagonists
07/20/2004US6765005 Fab I inhibitors
07/15/2004WO2004058781A1 Phosphonooxy quinazoline derivatives and their pharmaceutical use
07/15/2004WO2004058776A1 Therapeutic agents
07/15/2004WO2004058755A2 Compound libraries of imidazo[1,5-a]pyridin-3-yl derivatives and related heterobicycles for targetting compounds capable of binding to g-protein coupled receptors
07/15/2004WO2004058754A1 Benzoazolypiperazine derivatives having mglur1- and mglur5-antagonistic activity
07/15/2004WO2004058743A1 Novel substituted nitrogen-containing heterobicycles and use thereof as factor xa inhibitors
07/15/2004WO2004058741A1 Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
07/15/2004WO2004058730A2 Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
07/15/2004WO2004058729A1 New pyridazin-3(2h)-one derivatives
07/15/2004WO2004058722A1 Diarylamine and arylheteroarylamine pyrazole derivatives as modulators of 5ht2a
07/15/2004WO2004058721A2 Pyrazole derivatives modulators of hepatocyte growth factor (scatter factor) activity
07/15/2004WO2004058720A2 Compound libraries of 1,3,5-substitute indazole derivatives as compounds for targetting compounds capable of binding to the g-protein coupled receptor
07/15/2004WO2004058265A1 Compound libraries of 2,3-substituted pyrazine derivatives capable of binding to g-protein coupled receptors
07/15/2004WO2004058264A1 Compound libraries of 2h-spiro (isoquinoline-1, -piperidine derivatives and related compounds for targetting compounds capable of binding to the g-protein receptor
07/15/2004WO2004058263A1 Compound libraries of 2, 3, 4, 9-tetrahydrospiro (beta-carboline-1, 4 -piperidine) derivatives and related compounds for targetting compounds capable of binding to the g-protein receptor
07/15/2004WO2004058259A1 Compound libraries of n-(aminocarbonyl)-piperidine-4-carboxamide derivatives capable of binding to g-protein coupled receptors
07/15/2004WO2004050621A3 Indol derivatives and their use as kinase inhibitors
07/15/2004WO2004048345A3 2,5-diketopiperazines for the treatment of obesity
07/15/2004WO2004043366A3 Sulfonamides
07/15/2004WO2004039780A8 Novel alkyne compounds having an mch antagonistic effect and medicaments containing these compounds
07/15/2004WO2004039318A3 Anti-infective biaryl compounds
07/15/2004WO2004032846A3 Triazolone and triazolethione derivatives
07/15/2004WO2004006846A3 Receptor-type kinase modulators and methods of use
07/15/2004WO2003086294A3 1h-benzo[f]indazol-5-yl derivatives as selective glucocorticoid receptor modulators
07/15/2004WO2003047513A3 Method for treating ocular hypertension
07/15/2004US20040138451 Epindolidione pigments
07/15/2004US20040138450 Agriculture salts and oxides
07/15/2004US20040138309 Factor x inhibitor; anticoagulants
07/15/2004US20040138287 Novel 5-phenyl-1h-indole derivatives as antagonists of interleukine-8 receptors
07/15/2004US20040138286 Rho kinase inhibitors
07/15/2004US20040138284 Indol-3-yl derivatives
07/15/2004US20040138276 Metalloproteinase inhibitors
07/15/2004US20040138262 Antiinflammatory agents; antiallergens; vision defects; anticancer agents; gastrointestinal disorders
07/15/2004US20040138256 Process for the preparation of imidazole compounds
07/15/2004US20040138243 Antiinflammatory agents; asthma; Alzheimer's disease; Aids; antidiabetic agents; inflmamtory bowel disorders; anticholesterol agents; antitumor agenst
07/15/2004US20040138207 Antitumor agents
07/15/2004US20040138206 Novel sulfonamide derivatives, intermidiate thereof, its preparation methods, and pharmaceutical composition comprising the same
07/15/2004DE10300017A1 Selektive MMP 13 Inhibitoren Selective MMP inhibitors 13
07/15/2004DE10300015A1 Iminosäurederivate als Inhibitoren von Matrix-Metallproteinasen Iminosäurederivate as inhibitors of matrix metalloproteinases
07/15/2004CA2512099A1 New pyridazin-3(2h)-one derivatives
07/15/2004CA2511349A1 New substituted nitrogen-containing heterobicycles, the preparation thereof and their use as pharmaceutical compositions
07/15/2004CA2511199A1 Small molecule modulators of hepatocyte growth factor (scatter factor) activity
07/15/2004CA2508917A1 Therapeutic agents
07/14/2004EP1437348A1 6-methyl-2,4-diamino-pyrimidine derivatives, process for preparation, compositions containing them and their uses as basic neutralising agents